Over Rwf 4.9 billion to be invested in advancing genomics and precision medicine in Africa
During the World Health Summit Regional Meeting 2026 taking place in Nairobi, Kenya, a $3.5 million investment equivalent to more than Rwf 4.9 billion was announced to advance genomics and precision medicine across Africa.
The investment was unveiled through a partnership between Biolinx Africa, YTO Foundation, and Nextgen Molecular Lab. The partners say the initiative will strengthen Africa’s genomic research capacity and promote personalized healthcare tailored to individuals’ genetic profiles.
The project will initially be implemented in Kenya and Côte d’Ivoire, where the first 24 months will focus on expanding sequencing laboratory capacity, empowering African scientists and researchers, and enhancing systems for genomic data generation, processing, and analysis within Africa.
The partners will utilize the NovaSeq X Plus platform developed by Illumina, a high-throughput sequencing technology designed to deliver large-scale and rapid genomic analysis.
Although Africa is home to the world’s greatest human genetic diversity, African populations remain significantly underrepresented in global genomic studies and reference databases.
Experts say this gap often contributes to misdiagnosis, inaccurate interpretation of medical results, and reduced treatment effectiveness for African patients, since much of the existing genomic data is derived from non-African populations.
In recent years, genomics and precision medicine have increasingly been recognized as critical pillars for transforming healthcare systems across the continent. AUDA-NEPAD has already identified genomics as one of Africa’s scientific priorities, while Africa CDC reports that six African countries have launched national genomics strategies, with 11 others finalizing implementation plans.
In February 2026, the World Health Organization also adopted a resolution encouraging countries to invest in genomics, pharmacogenomics, advanced laboratory infrastructure, bioinformatics, and genomic databases.
Dr. Robert Karanja, Founder and Chief Executive Officer of Biolinx Africa, said the time has come for Africa to move beyond discussions and build real operational capacity capable of transforming healthcare systems. He noted that the partnership aims to combine infrastructure, investment, and African scientific expertise to deliver sustainable and practical solutions.
Prof. David Téa Okou, a clinical molecular geneticist and founder of YTO Foundation, emphasized that African populations remain underrepresented in the genomic data increasingly used to guide prevention, diagnosis, and treatment decisions. He said the initiative will help generate data that is more relevant to African patients and improve healthcare outcomes across the continent.
Meanwhile, Dr. George Michuki, Chief Executive Officer of Nextgen Molecular Lab, explained that pharmacogenomics can help scientists better understand why patients respond differently to medications, particularly in cancer treatment, paving the way for more personalized therapeutic approaches.
The partners added that the collaboration emerged through the African Voices of Science network, established by Speak Up Africa in 2020 to amplify African scientific voices in global health discussions. They say the long-term vision is to expand the initiative to more African countries as infrastructure, expertise, and partnerships continue to grow.
